Contact: Steve Graff
Thomas Jefferson University
Caption: An investigation led by John M. Pascal, Ph.D., an assistant professor in the Department of Biochemistry and Molecular Biology at Thomas Jefferson University and Jefferson's Kimmel Cancer Center, revealed new target sites for drugs aiming to stop PARP-1 activity.
Credit: Thomas Jefferson University
Usage Restrictions: None
Related news release: A closer look at PARP-1 reveals potential new drug targets